Abstract Body

Background:

Uncontrolled SARS-CoV-2 infection is associated with disorders of the innate immune and delayed adaptive immune systems. Yet, it remains unclear how SARS-CoV-2 causes local and systemic dysregulation. The role of the complement system in SARS-CoV-2 pathogenesis is well established, in particular as a driver of systemic inflammation which is characteristic of severe COVID-19. Although complement is traditionally known as a central arm of innate immunity, it has equally important roles in the regulation of adaptive immunity. However, how mechanistic complement affects dendritic cell (DC) functionality and T cell-priming upon SARS-CoV-2 infection, is still poorly defined.

Methods:

Effects of differently opsonized SARS-CoV-2-loaded primary DCs were measured by RT-PCR, ELISA, PathScan and flow cytometry. Co-culture with naïve CD4+ and CD8+ T cells, T-cell activation, cytotoxic T-cells GRZB/PRF production and SARS-CoV-2–specific cytokine-producing T-cells were measured by flow cytometry and ELISpot.

Results:

DC were not susceptible to SARS-CoV-2 infection, and exposure to SARS-CoV-2 triggered neither induction nor secretion of type-I IFN and inflammatory cytokines. Notably, complement-opsonized-SARS-CoV-2 loaded-DCs displayed enhanced maturation and efficient type-I IFN and IL-1β responses, suggesting that complement is crucial for mediating immunity against SARS-CoV-2. Here, we describe that IL-1β secretion occurs following intracellular caspase-1 activation by inflammasome activation, revealing a mechanistic link between complement and IL-1β secretion in human DCs. Strikingly, complement-triggered IL-1β production was mediated by the mammalian target of rapamycin (mTOR). NLRP3 inhibition resulted in impaired priming of IFN-gamma-producing CD4+ and CD8+ T cells, suggesting an essential role of complement in increasing antigen-specific T-cell responses.

Conclusions:

The potential for myeloid cells to act as bona fide targets of SARS-CoV-2 infection remains unclear. Here, we show that complement-opsonized SARS-CoV-2 induces type I IFN secretion, upregulates the mTOR pathway and directly activates NLRP3, which leads to IL-1ß secretion. The role of IL-1 β as part of the bridge between innate and adaptive immunity may be clinically translated into therapeutic strategies to empower the formation of T cell immunity. Our data demonstrate distinct immunological functions for DCs and consider the role of complement and mTOR activation in regulating immune system responses in SARS-CoV-2 infection.